As of 2026-04-04, the Intrinsic Value of Genprex Inc (GNPX) is -37.25 USD. This GNPX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.54 USD, the upside of Genprex Inc is -2,519.10%.
Based on its market price of 1.54 USD and our intrinsic valuation, Genprex Inc (GNPX) is overvalued by 2,519.10%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -37.25 - -37.25 | -37.25 | -2,519.10% |
| P/E | (140.82) - (159.89) | (153.49) | -10066.7% |
| DDM - Stable | (41.79) - (143.69) | (92.74) | -6122.0% |
| DDM - Multi | (44.91) - (126.16) | (66.92) | -4445.7% |
| Market Cap (mil) | 3.57 |
| Beta | -0.33 |
| Outstanding shares (mil) | 2.32 |
| Enterprise Value (mil) | 2.47 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.57% |
| Cost of Debt | 5.00% |
| WACC | 8.12% |